FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200508731> ?p ?o ?g. }

• W4200508731 abstract "Abstract As the COVID-19 pandemic evolves, and vaccine rollout progresses, the availability and demand for monoclonal antibodies for the prevention and treatment of SARS-CoV-2 infection are also accelerating. This longitudinal serological study evaluated the magnitude and potency of the endogenous antibody response to COVID-19 vaccination in participants who first received a COVID-19 monoclonal antibody in a prevention study. Over the course of six months, serum samples were collected from the prevention population (nursing home residents and staff) enrolled in the BLAZE-2 clinical trial who had received either bamlanivimab (4200 mg) or placebo. In an unplanned component of this trial, a subset of these participants was subsequently fully vaccinated with two doses of either SpikeVax (Moderna) or Comirnaty (BioNTech/Pfizer) COVID-19 mRNA vaccines, as part of the US vaccination program. This post-hoc analysis assessed the immune response to vaccination for the subset of participants (N=135) without prior SARS-CoV-2 infection. Antibody titers and potency were assessed using three assays against SARS-CoV-2 proteins that bamlanivimab does not significantly bind to, thereby reflecting the endogenous antibody response. All bamlanivimab and placebo participants mounted a robust immune response to full COVID-19 vaccination, irrespective of age, risk-category and vaccine type, with any observed differences unlikely to be clinically meaningful. These findings are pertinent for informing public health policy with results that suggest a complementary role for COVID-19 monoclonal antibodies (mAbs) with COVID-19 vaccines and that the benefit of receiving COVID-19 vaccination at the earliest opportunity outweighs the minimal effect on the endogenous immune response due to prior prophylactic COVID-19 mAb infusion. One Sentence Summary Individuals infused with an anti-SARS-CoV-2 antibody demonstrated a robust immune response to subsequent full COVID-19 vaccination." @default.
• W4200508731 created "2021-12-31" @default.
• W4200508731 creator A5007939963 @default.
• W4200508731 creator A5009877835 @default.
• W4200508731 creator A5024262342 @default.
• W4200508731 creator A5029525028 @default.
• W4200508731 creator A5030604404 @default.
• W4200508731 creator A5032896541 @default.
• W4200508731 creator A5039577185 @default.
• W4200508731 creator A5051929582 @default.
• W4200508731 creator A5052240068 @default.
• W4200508731 creator A5054743162 @default.
• W4200508731 creator A5058673240 @default.
• W4200508731 creator A5063855371 @default.
• W4200508731 creator A5065700713 @default.
• W4200508731 creator A5066654486 @default.
• W4200508731 creator A5070647012 @default.
• W4200508731 creator A5089233990 @default.
• W4200508731 date "2021-12-16" @default.
• W4200508731 modified "2023-10-18" @default.
• W4200508731 title "The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination" @default.
• W4200508731 cites W2001010891 @default.
• W4200508731 cites W2034600163 @default.
• W4200508731 cites W2046974419 @default.
• W4200508731 cites W2128056712 @default.
• W4200508731 cites W2911721746 @default.
• W4200508731 cites W3012650581 @default.
• W4200508731 cites W3016900702 @default.
• W4200508731 cites W3024289893 @default.
• W4200508731 cites W3032255042 @default.
• W4200508731 cites W3036386821 @default.
• W4200508731 cites W3046396978 @default.
• W4200508731 cites W3047719754 @default.
• W4200508731 cites W3081916995 @default.
• W4200508731 cites W3092136311 @default.
• W4200508731 cites W3111255098 @default.
• W4200508731 cites W3111431752 @default.
• W4200508731 cites W3125404264 @default.
• W4200508731 cites W3125712166 @default.
• W4200508731 cites W3135768856 @default.
• W4200508731 cites W3138734145 @default.
• W4200508731 cites W3149428818 @default.
• W4200508731 cites W3152531891 @default.
• W4200508731 cites W3155123963 @default.
• W4200508731 cites W3158223263 @default.
• W4200508731 cites W3163785571 @default.
• W4200508731 cites W3164547793 @default.
• W4200508731 cites W3164832774 @default.
• W4200508731 cites W3176479223 @default.
• W4200508731 cites W3189985782 @default.
• W4200508731 cites W3191296753 @default.
• W4200508731 cites W3192612429 @default.
• W4200508731 cites W3196397911 @default.
• W4200508731 cites W3199126560 @default.
• W4200508731 cites W4200330404 @default.
• W4200508731 cites W4205483821 @default.
• W4200508731 cites W4210574840 @default.
• W4200508731 doi "https://doi.org/10.1101/2021.12.15.21267605" @default.
• W4200508731 hasPublicationYear "2021" @default.
• W4200508731 type Work @default.
• W4200508731 citedByCount "2" @default.
• W4200508731 countsByYear W42005087312022 @default.
• W4200508731 crossrefType "posted-content" @default.
• W4200508731 hasAuthorship W4200508731A5007939963 @default.
• W4200508731 hasAuthorship W4200508731A5009877835 @default.
• W4200508731 hasAuthorship W4200508731A5024262342 @default.
• W4200508731 hasAuthorship W4200508731A5029525028 @default.
• W4200508731 hasAuthorship W4200508731A5030604404 @default.
• W4200508731 hasAuthorship W4200508731A5032896541 @default.
• W4200508731 hasAuthorship W4200508731A5039577185 @default.
• W4200508731 hasAuthorship W4200508731A5051929582 @default.
• W4200508731 hasAuthorship W4200508731A5052240068 @default.
• W4200508731 hasAuthorship W4200508731A5054743162 @default.
• W4200508731 hasAuthorship W4200508731A5058673240 @default.
• W4200508731 hasAuthorship W4200508731A5063855371 @default.
• W4200508731 hasAuthorship W4200508731A5065700713 @default.
• W4200508731 hasAuthorship W4200508731A5066654486 @default.
• W4200508731 hasAuthorship W4200508731A5070647012 @default.
• W4200508731 hasAuthorship W4200508731A5089233990 @default.
• W4200508731 hasBestOaLocation W42005087311 @default.
• W4200508731 hasConcept C126322002 @default.
• W4200508731 hasConcept C142724271 @default.
• W4200508731 hasConcept C159047783 @default.
• W4200508731 hasConcept C159654299 @default.
• W4200508731 hasConcept C202751555 @default.
• W4200508731 hasConcept C203014093 @default.
• W4200508731 hasConcept C204787440 @default.
• W4200508731 hasConcept C22070199 @default.
• W4200508731 hasConcept C22889606 @default.
• W4200508731 hasConcept C27081682 @default.
• W4200508731 hasConcept C2779134260 @default.
• W4200508731 hasConcept C2780441014 @default.
• W4200508731 hasConcept C2908647359 @default.
• W4200508731 hasConcept C3008058167 @default.
• W4200508731 hasConcept C32611913 @default.
• W4200508731 hasConcept C45189115 @default.
• W4200508731 hasConcept C524204448 @default.
• W4200508731 hasConcept C535046627 @default.
• W4200508731 hasConcept C542903549 @default.
• W4200508731 hasConcept C55493867 @default.

• next